|
2024
|
Invention
|
Quinones for use in the treatment of red blood cell enzymopathies. Class of quinones for use in t... |
|
|
Invention
|
Quinones for use in the treatment of red blood cell enzymopathies. Classes of quinones for use in... |
|
2022
|
Invention
|
Succinate prodrug, compositions containing the succinate prodrug and uses thereof. The present in... |
|
|
Invention
|
Kl1333 for use in medicine.
The present invention relates to
i) KL1333 for us... |
|
|
Invention
|
Kl1333 for use in medicine. The present invention relates to i) KL1333 for use in the treatment o... |
|
|
Invention
|
Kl1333 for use in the treatment of fatigue. The present invention relates to i) KL1333 for use in... |
|
2021
|
Invention
|
Cell-permeable succinate compounds. The present invention provides novel cell-permeable succinate... |
|
2020
|
P/S
|
Medical research; research in the field of biotechnology; research in the field of genetic engine... |
|
|
P/S
|
Medical research; research relating to biotechnology; clinical research in the field of mitochond... |
|
|
P/S
|
Medical research; research relating to biotechnology;
clinical research; conducting clinical tri... |
|
|
P/S
|
Medical research; Research relating to biotechnology; Clinical research; Conducting clinical tria... |
|
|
P/S
|
Chemical preparations for pharmaceutical purposes; Medicines for human purposes; Pharmaceutical d... |
|
2018
|
P/S
|
esters for foodstuffs, not for pharmaceutical purposes. Fungicides, herbicides; preparations for ... |
|
|
P/S
|
esters for foodstuffs, not for pharmaceutical purposes. Acetates for pharmaceutical purposes; aci... |
|
|
P/S
|
[ Acetates for pharmaceutical purposes; acids for pharmaceutical purposes; adjuvants for medical ... |
|
|
P/S
|
Esters for veterinary use; esters for veterinary purposes;
esters for foodstuffs, not for pharma... |
|
|
P/S
|
esters for foodstuffs, not for pharmaceutical purposes. Fungicides, herbicides; other preparation... |
|
|
P/S
|
Acetates for pharmaceutical purposes; acids for pharmaceutical purposes; adjuvants for medical pu... |
|
2017
|
Invention
|
Use of sanglifehrin macrocyclic analogues as anticancer compounds. The present invention relates ... |
|
2016
|
Invention
|
Succinate prodrugs for use in the treatment of lactic acidosis or drug-induced side-effects due t... |
|
2015
|
Invention
|
Novel cell-permeable succinate compounds. The present invention provides novel cell-permeab... |
|
2014
|
P/S
|
Pharmaceutical preparations for medical use consisting of a
cyclosporin or another cyclophilin i... |
|
2013
|
Invention
|
Protected succinates for enhancing mitochondrial atp-production. 2 is independently a group accor... |
|
2012
|
Invention
|
Dosage form. There is provided inter alia a pharmaceutical dosage form for oral administration co... |
|
|
Invention
|
Macrocyclic compounds and methods for their production. There is provided inter alia compounds of... |
|
|
Invention
|
Compound and methods for its production. There is provided inter alia a compound of formula (I):
... |
|
|
P/S
|
Pharmaceutical preparations for medical use consisting of a cyclosporin as active agent and dilue... |
|
2011
|
Invention
|
Sanglifehrin derivatives and methods for their production. There are provided inter alia compound... |
|
|
Invention
|
Cyclosporine emulsion. The present invention relates to a cyclosporine emulsion containing: i) a ... |
|
|
Invention
|
Sanglifehrin based compounds. There are provided inter alia compounds of formula (I)
useful as ... |
|
2007
|
P/S
|
Pharmaceutical and veterinary preparations; including
medicines and pharmaceutical preparations ... |
|
|
P/S
|
Pharmaceutical and veterinary preparations; sanitary
preparations for medical purposes; dietetic... |
